Martin Bossart,Andreas Evers,Torsten Haack,Katrin Lorenz,Dieter Kadereit,Michael Wagner,Stefania Pfeiffer-Marek,Martin Lorenz
申请号：
US15829698
公开号：
US10519211B2
申请日:
2017.12.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to trigonal GLP-1/glucagon/GIP receptor agonists and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as for reduction of excess food intake.
